THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A...
Strategic transaction supports the advancement of Decoy’s rapid computational design and manufacturing of innovative peptide conjugate therapeutics through its IMP3ACT™...
Completion of treatment for the first 45 patients on pace for Q1 2026 with initial unblinded data thereafter; blinded response...
Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819,...
Once issued, this new U.S. patent covers the use of CardiolRx™ and CRD-38 for a broad range of cardiac disorders,...
Once issued, this new U.S. patent covers the use of CardiolRx™ and CRD-38 for a broad range of cardiac disorders,...
SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced the closing...
IgniteData's Archer platform will connect the site's EHR system, Advarra's eSource and EDC systems, and the sponsor's EDC system of...
Patent Extends Protection for Novel Vaccine Targeting a Cancer Projected to Strike Nearly 300,000 U.S. Women in 2026 SAN JOSE,...
New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in human keratinocytes, demonstrating potent...
The Winn Awards community welcomes 79 new physician-researchers from 23 states NORTHAMPTON, MA / ACCESS Newswire / November 12, 2025...
- Former Chimerix (CMRX, acquired by Jazz for $935 million) Senior Commercial Leader Michael Grabow led Go-To-Market Strategy and Launch...
Preclinical research to be conducted at the University of North Carolina at Chapel Hill (UNC) Annamycin will be used in...
Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - November 12, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)...
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with...
Dr. Gildea and Dr. Ötvös Named Newest Members of Medical & Scientific Affairs CENTER VALLEY, Pa., Nov. 11, 2025 /PRNewswire/...
BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA...
Adoption of DeepScribe's ambient AI for oncology takes off across community settings, delivering measurable gains in clinician experience and diagnostic...
Company Marks Key Milestone in AI-Enhanced Cancer Diagnostics HOUSTON, Nov. 11, 2025 /PRNewswire/ -- EXoPERT, a biotechnology company pioneering AI-powered exosome-based liquid...
BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine,...